Additionally, Chinese researchers have made unique contributions to LT for hepatocellular carcinoma (HCC), with Xiao et al. identifying chitinase-3-like protein 1 (CHI3L1) as a biomarker associated with both sarcopenia and tumor recurrence risk [58,59]. Here, CHI3L1 is linked to hepatocellular carcinoma.